AAAAAA
Results: 1-25/32
Authors:
Osby, E
Taube, A
Cavallin-Stahl, E
Hagberg, H
Bjorkholm, M
Citation: E. Osby et al., Reproducibility of tumor response evaluation in patients with high-grade malignant non-Hodgkin's lymphoma, MED ONCOL, 18(2), 2001, pp. 137-140
Authors:
Axdorph, U
Porwit-MacDonald, A
Grimfors, G
Bjorkholm, M
Citation: U. Axdorph et al., Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease, LEUK LYMPH, 42(5), 2001, pp. 1055
Authors:
Johansson, E
Bjorkholm, M
Wredling, R
Kalin, M
Engervall, P
Citation: E. Johansson et al., Outpatient parenteral antibiotic therapy in patients with haematological malignancies - A pilot study of an early discharge strategy, SUPP CARE C, 9(8), 2001, pp. 619-624
Authors:
Sundblad, A
Porwit, A
Ostad, M
Nennesmo, I
Holm, G
Osby, E
Borg, K
Bjorkholm, M
Citation: A. Sundblad et al., Antibody reactivities to skeletal muscle proteins in a patient with lambdalight chain secreting multiple myeloma, generalised amyloidosis and rhabdomyolysis, EUR J HAEMA, 67(3), 2001, pp. 189-193
Authors:
Malec, M
Bjorklund, E
Soderhall, S
Mazur, J
Sjogren, AM
Pisa, P
Bjorkholm, M
Porwit-MacDonald, A
Citation: M. Malec et al., Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL, LEUKEMIA, 15(5), 2001, pp. 716-727
Authors:
Lindvall, C
Nordenskjold, M
Porwit, A
Bjorkholm, M
Blennow, E
Citation: C. Lindvall et al., Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements, HAEMATOLOG, 86(11), 2001, pp. 1158-1164
Authors:
Bjorkholm, M
Runarsson, G
Celsing, F
Kalin, M
Petrini, B
Engervall, P
Citation: M. Bjorkholm et al., Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia, SC J IN DIS, 33(4), 2001, pp. 316-319
Authors:
Xu, DW
Popov, N
Hou, M
Wang, Q
Bjorkholm, M
Gruber, A
Menkel, AR
Henriksson, M
Citation: Dw. Xu et al., Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells, P NAS US, 98(7), 2001, pp. 3826-3831
Authors:
Zheng, C
Huang, DR
Liu, L
Wu, RH
Glas, SB
Osterborg, A
Bjorkholm, M
Holm, G
Yi, Q
Sundblad, A
Citation: C. Zheng et al., Interleukin-10 gene promoter polymorphisms in multiple myeloma, INT J CANC, 95(3), 2001, pp. 184-188
Authors:
Hou, M
Xu, DW
Bjorkholm, M
Gruber, A
Citation: M. Hou et al., Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity, CLIN CHEM, 47(3), 2001, pp. 519-524
Authors:
Zheng, CY
Huang, DR
Liu, L
Bjorkholm, M
Holm, G
Yi, Q
Sundblad, A
Citation: Cy. Zheng et al., Cytotoxic T-lymphocyte antigen-4 microsatellite polymorphism is associatedwith multiple myeloma, BR J HAEM, 112(1), 2001, pp. 216-218
Authors:
Xu, D
Zheng, C
Bergenbrant, S
Holm, G
Bjorkholm, M
Yi, Q
Gruber, A
Citation: D. Xu et al., Telomerase activity in plasma cell dyscrasias, BR J CANC, 84(5), 2001, pp. 621-625
Authors:
Steingrimsdottir, H
Gruber, A
Kalin, M
Bjorkholm, M
Citation: H. Steingrimsdottir et al., Late infections after blood progenitor cell transplantation in patients with multiple myeloma, AM J MED, 110(4), 2001, pp. 329-330
Authors:
Landgren, O
Axdorph, U
Jacobsson, H
Johansson, B
Grimfors, G
Bjorkholm, M
Citation: O. Landgren et al., Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease, MED ONCOL, 17(3), 2000, pp. 174-178
Authors:
Teramoto, N
Gogolak, P
Nagy, N
Maeda, A
Kvarnung, K
Bjorkholm, M
Klein, E
Citation: N. Teramoto et al., Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle, J HUMAN VIR, 3(3), 2000, pp. 125-136
Authors:
Panagopoulos, I
Isaksson, M
Lindvall, C
Bjorkholm, M
Ahlgren, T
Fioretos, T
Heim, S
Mitelman, F
Johansson, B
Citation: I. Panagopoulos et al., RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13), GENE CHROM, 28(4), 2000, pp. 415-424
Authors:
Xu, DW
Wang, Q
Gruber, A
Bjorkholm, M
Chen, ZG
Zaid, A
Selivanova, G
Peterson, C
Wiman, KG
Pisa, P
Citation: Dw. Xu et al., Downregulation of telomerase reverse transcriptase mRNA expression by wildtype p53 in human tumor cells, ONCOGENE, 19(45), 2000, pp. 5123-5133
Authors:
Axdorph, U
Sjoberg, J
Grimfors, G
Landgren, O
Porwit-MacDonald, A
Bjorkholm, M
Citation: U. Axdorph et al., Biological markers may add to prediction of outcome achieved by the international prognostic score in Hodgkin's disease, ANN ONCOL, 11(11), 2000, pp. 1405-1411
Authors:
Steingrimsdottir, H
Gruber, A
Bjorkholm, M
Svensson, A
Hansson, M
Citation: H. Steingrimsdottir et al., Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications, HAEMATOLOG, 85(8), 2000, pp. 832-838
Authors:
Celsing, F
Ekman, G
Granstrom, L
Johnsson, H
Bjorkholm, M
Citation: F. Celsing et al., Caesarean section in previously untreated acute promyelocytic leukaemia - Report of two patients, EUR J OB GY, 91(1), 2000, pp. 41-42
Authors:
Zhang, AJ
Zheng, CY
Lindvall, C
Hou, M
Ekedahl, J
Lewensohn, R
Yan, ZQ
Yang, XY
Henriksson, M
Blennow, E
Nordenskjold, M
Zetterberg, A
Bjorkholm, M
Gruber, A
Xu, DW
Citation: Aj. Zhang et al., Frequent amplification of the Telomerase Reverse Transcriptase gene in human tumors, CANCER RES, 60(22), 2000, pp. 6230-6235
Authors:
Zheng, CY
Huang, DR
Bergenbrant, S
Sundblad, A
Osterborg, A
Bjorkholm, M
Holm, G
Yi, Q
Citation: Cy. Zheng et al., Interleulkin 6, tumour necrosis factor alpha, interleukin 1 beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma, BR J HAEM, 109(1), 2000, pp. 39-45
Authors:
Engervall, P
Kalin, M
Dornbusch, K
Bjorkholm, M
Citation: P. Engervall et al., Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: A randomized, single-center phase II trial, J CHEMOTHER, 11(4), 1999, pp. 278-286
Authors:
Palucka, KA
Knaust, E
Xu, DW
Macnamara, B
Porwit-MacDonald, A
Gruber, A
Peterson, C
Bjorkholm, M
Pisa, P
Citation: Ka. Palucka et al., Intraclonal heterogeneity in the in vitro daunorubicin-induced apoptosis in acute myeloid leukemia, LEUK LYMPH, 32(3-4), 1999, pp. 309-316
Authors:
Andreasson, B
Wahlstrom, E
Jacobsson, S
Bjorkholm, M
Samuelsson, J
Birgegard, G
Wadenvik, H
Kutti, J
Citation: B. Andreasson et al., The measurement of venous haematocrit in patients with polycythaemia vera, J INTERN M, 246(3), 1999, pp. 293-297